H.R. 2383 (119th)Bill Overview

Protecting Kids from Fentanyl Act of 2025

Health|Health
Cosponsors
Support
Lean Democratic
Introduced
Mar 26, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill amends the Public Health Service Act to allow Preventive Health and Health Services Block Grants to buy naloxone or other opioid antagonists for schools. It also authorizes training for school nurses, teachers, administrators, and resource officers on antagonist administration, and permits providing fentanyl awareness classes or materials to students.

Why people may split

Liberal emphasizes harm reduction and lifesaving access

Watch point

Relative to its intended legislative type, this bill clearly and narrowly amends the Public Health Service Act to authorize use of Preventive Health and Health Services Block Grants to purchase opioid antagonists for educational institutions and to provide related training and student awareness.

The bill amends the Public Health Service Act to allow Preventive Health and Health Services Block Grants to buy naloxone or other opioid antagonists for schools.

It also authorizes training for school nurses, teachers, administrators, and resource officers on antagonist administration, and permits providing fentanyl awareness classes or materials to students.

Passage65/100

Small, technical public-health measure using existing funds; historically similar measures often advance, though procedural hurdles remain.

CredibilityPartially aligned

Relative to its intended legislative type, this bill clearly and narrowly amends the Public Health Service Act to authorize use of Preventive Health and Health Services Block Grants to purchase opioid antagonists for educational institutions and to provide related training and student awareness. The statutory amendment is precise in placement and cross-reference updates but leaves substantial implementation, funding, definitional, oversight, and risk-mitigation detail to existing grant authorities or later guidance.

Contention55/100

Liberal emphasizes harm reduction and lifesaving access

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Students · SchoolsStates · Schools

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • StudentsIncreased availability of naloxone in schools could reduce fatal opioid overdoses among students and staff.
  • SchoolsTraining for school personnel can speed emergency response times during suspected overdoses.
  • StudentsGrant-funded education may raise student awareness and reduce accidental fentanyl exposures.
Likely burdened
  • StatesStates may redirect block grant funds away from other preventive services to fund these activities.
  • SchoolsImplementation could create additional administrative and recordkeeping burdens for school systems.
  • StatesUneven state uptake could lead to geographic disparities in naloxone availability and training coverage.
03 · Why people split

Why the argument around this bill splits.

Liberal emphasizes harm reduction and lifesaving access
Progressive95%

Supports the bill as a targeted harm-reduction and student-safety measure that can prevent overdose deaths in schools.

Would view training and awareness as helpful complements to prevention and calls for adequate funding and inclusive curricula.

Leans supportive
Centrist70%

Generally favorable as a pragmatic, limited public-health step to reduce youth overdose fatalities.

Sees value but seeks clarity on costs, oversight, and whether funds divert other prevention programs.

Leans supportive
Conservative35%

Mixed to skeptical: may accept naloxone for emergency use but worries about federal expansion into schools and student-facing fentanyl classes.

Concerns include parental rights, local control, and potential unintended messaging about drug use.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood65/100

Small, technical public-health measure using existing funds; historically similar measures often advance, though procedural hurdles remain.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No cost estimate or CBO score in bill text
  • Potential objections from members opposed to harm-reduction approaches
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberal emphasizes harm reduction and lifesaving access

Small, technical public-health measure using existing funds; historically similar measures often advance, though procedural hurdles remain.

Unlocked analysis

Relative to its intended legislative type, this bill clearly and narrowly amends the Public Health Service Act to authorize use of Preventive Health and Health Services Block Grants to purchase opioid antagonists for ed…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis